title: Providing patients with information on pharmacogenetic testing.
abstract: This article outlines the key issues to be considered before recommending the use of pharmacogenetic tests, which may predict a patient's response to a particular drug.
authors.affiliation: Liverpool Reviews and Implementation Group, University of Liverpool. nigel.fleeman@liverpool.ac.uk
authors.forename: Nigel
authors.initials: N
authors.lastname: Fleeman
authors.forename: Rumona
authors.initials: R
authors.lastname: Dickson
mesh_terms: D055317:Evidence-Based Practice; D005817:Genetic Counseling / Q000379:methods*; D005820:Genetic Testing / Q000379:methods*; D006801:Humans; D007258:Informed Consent; D010353:Patient Education as Topic / Q000379:methods*; D018579:Patient Selection; D010597:Pharmacogenetics / Q000193:education* / Q000941:ethics / Q000331:legislation & jurisprudence / Q000379:methods* / Q000592:standards; D015203:Reproducibility of Results; D006113:United Kingdom; D014481:United States; D014486:United States Food and Drug Administration